GMV 0.00% 3.9¢ g medical innovations holdings limited

Given his definition of "soon" in the context of the Q1...

  1. 1,142 Posts.
    lightbulb Created with Sketch. 675
    Given his definition of "soon" in the context of the Q1 conference call; and his definition of "January" in relation to Guthy-Renker: what's the time frame when Yacov says "we are preparing NMPA files" which we "hope to submit" by the "end of the year"?

    Let's look at the words he chose on Jan 17 2020, in an official announcement to ASX, headed "PRIZMA CLINICAL TRIALS COMPLETED FOR CHINA NMPA APPROVAL PROCESS."

    Quite a positive headline, don't you think?

    Yacov Geva announced: "The Company will shortly lodge the required documentation to the regulator and we are confident that NMPA approval will be received towards the middle of the year." The middle of 2020. Not after the middle. Towards the middle.

    Let's see. It's now 2022. Two years later. Obviously, none of that happened.

    BECAUSE IT WAS TOTAL BS.
    SHAMELESS MARKET DECEPTION.
    IN AN ASX ANNOUNCEMENT.

    And now we're meant to believe him when he says "we are preparing"??? "Hope to submit"??? "End of year"???

    Yacov Geva is a shameless BS'ing conman. He made an official announcement GMV wouldn't delist from ASX. If he announces something, the opposite is true. Next he'll announce another NMPA inspector has died.
    https://hotcopper.com.au/data/attachments/4321/4321137-3591a36f9b13ffe67797e08b8f7ef766.jpg
    https://hotcopper.com.au/data/attachments/4321/4321141-1323f9fcac107ea01540bd8a865fa678.jpg
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.